essential thrombocythemia

USAGE SUMMARY

The phrase "essential thrombocythemia" is correct and usable in written English.
It is typically used in a medical context to refer to a blood disorder characterized by an elevated platelet count. Example: "The patient was diagnosed with essential thrombocythemia, which requires careful monitoring and treatment."

✓ Grammatically correct

Science

Human-verified examples from authoritative sources

Exact Expressions

60 human-written examples

essential thrombocythemia.

Clinical and Translational Medicine

Essential thrombocythemia (ET) is classified as a myeloproliferative neoplasm.

JA Clinical Reports

Myeloproliferative diseases (MPD) include polycythemia vera (PV), essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.

Seminars in Hematology

Essential thrombocythemia (ET) patients are at risk of developing thrombotic events.

Translational Research

Thirty-eight patients were enrolled and treated (31 myelofibrosis, 6 polycythemia vera, 1 essential thrombocythemia).

Leukemia Research

In the past essential thrombocythemia was considered a disease of the elderly.

American Journal of Obstetrics and Gynecology

In 1920, di Guglielmo established criteria for patients with essential thrombocythemia (ET).

Cytokine & Growth Factor Reviews

In this study, we analyzed oxidative stress in patients with essential thrombocythemia (ET) and polycythemia vera (PV).

Clinical Biochemistry

Essential thrombocythemia (ET) is one of several myeloproliferative neoplasms in which sustained proliferation of megakaryocytes leads to an excess of circulating thrombocytes (platelets).

Clinical and Translational Medicine

A bone marrow biopsy was performed on postoperative day 8, which revealed hypercellular marrow with megakaryocyte proliferation, and the patient was diagnosed as having essential thrombocythemia (ET).

JA Clinical Reports

Mutations in Janus kinase 2 (Jare) are implicated in the pathogenesis of Philadelphia-chromosome negative myeloproliferative neoplasms, including primary myelofibrosis, polycythemia vera, and essential thrombocythemia.

Leukemia Research

Expert writing Tips

Best practice

When writing about "essential thrombocythemia", ensure to specify whether you are referring to the diagnosis, the genetic mutations associated with it (like JAK2 or CALR), or the clinical management strategies.

Common error

Avoid using "essential thrombocythemia" when referring to reactive thrombocytosis, which is a temporary increase in platelet count due to another underlying condition (e.g. infection or inflammation). "Essential thrombocythemia" is a chronic myeloproliferative neoplasm.

Linguistic Context

The primary grammatical function of "essential thrombocythemia" is as a noun phrase, typically used as the subject or object of a sentence when discussing a specific medical condition. Ludwig examples illustrate its use in scientific literature.

Expression frequency: Very common

Frequent in

Science

100%

Less common in

News & Media

0%

Formal & Business

0%

Encyclopedias

0%

Ludwig's WRAP-UP

In summary, "essential thrombocythemia" is a noun phrase denoting a specific chronic myeloproliferative neoplasm, primarily used within formal scientific and medical contexts. Ludwig confirms its correct usage. The Ludwig AI analysis highlights its common appearance in scientific literature, emphasizing its role in accurate communication within medical fields. While grammatically sound, it's important to differentiate it from reactive thrombocytosis to avoid misinterpretations.

More alternative expressions

Phrases that express similar concepts, ordered by semantic similarity:

primary thrombocythemia

Uses "primary" instead of "essential" to describe the condition, but maintains the core meaning.

essential thrombocytosis

Replaces "thrombocythemia" with "thrombocytosis", both terms relate to elevated platelet count.

myeloproliferative thrombocythemia

Adds "myeloproliferative", specifying the type of neoplasm involved.

clonal thrombocythemia

Highlights the clonal nature of the disease origin.

JAK2-positive thrombocythemia

Identifies the presence of the JAK2 mutation, a common genetic marker.

CALR-mutated thrombocythemia

Specifies the presence of CALR mutation in thrombocythemia.

MPN-associated thrombocythemia

Associates the condition with myeloproliferative neoplasms (MPN).

high platelet count due to myeloproliferative disorder

Describes the condition in terms of its symptoms and underlying cause, a more descriptive alternative.

thrombocytosis related to bone marrow disorder

Generalizes the condition as thrombocytosis originating from a bone marrow issue.

reactive thrombocytosis in myeloproliferative neoplasms

Replaces "essential" with the term "reactive", and broadens the context to myeloproliferative neoplasms.

FAQs

How is "essential thrombocythemia" diagnosed?

Diagnosis involves blood tests to confirm elevated platelet counts, bone marrow biopsy to assess megakaryocyte proliferation, and genetic testing to identify mutations such as JAK2, CALR, or MPL. Exclusion of reactive causes of thrombocytosis is also crucial.

What are the treatment options for "essential thrombocythemia"?

Treatment strategies vary based on risk stratification. Low-risk patients may only require monitoring, while higher-risk patients may need cytoreductive therapies like hydroxyurea or anagrelide, and/or antiplatelet agents like aspirin.

What are the alternative names for "essential thrombocythemia"?

The most common alternative name is "primary thrombocythemia". The term "essential thrombocytosis" is also used.

What is the difference between "essential thrombocythemia" and reactive thrombocytosis?

"Essential thrombocythemia" is a chronic myeloproliferative neoplasm characterized by autonomous platelet production, while reactive thrombocytosis is a secondary increase in platelet count due to an underlying condition like infection, inflammation, or iron deficiency.